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Background
Matrix Gla-protein (MGP) is one of the strongest inhibitor
of vascular calcification, produced by many cells,
including vascular smooth muscle cells and
chondrocytes. Circulating dp-ucMGP reflects the amount
of uncarboxylated MGP produced in the arterial vessel
wall and is a direct marker for the vascular vitamin K
status. Different studies, using cumbersome ELISA
methods, have shown conflicting results regarding the
association of dp-ucMGP and abdominal aortic
Results
Precision
Within-run %CV were 2.9 - 8.9%. Total %CV were 4.1 - 13.4%.
Linearity
Obtained = 0.95 x Expected + 209, R²=0.99 in 18 dilutions.
Method Comparison
calcification score. We assess the performance of the
fully automated IDS-iSYS InaKtif MGP assay (IDS, UK)
and compare the results vs. an ELISA method in a
cohort of haemodialysis patients.
Materials and Methods
 Precision profile: determined with 4 plasma pool levels
twice a day for 10 days.
 Linearity: verified with 2 sets of high/low plasma
 Method comparison: plasma samples. from              
175 patients
─ Without Vitamin K supplementation,
─ Under thrice-weekly hemodialysis for at least 
3 months,
─ Mean age 68.7±14.4 years,
─ Median dialysis vintage: 21 months (3 – 396)
─ 78 (65.0%) had history of cardiovascular diseases.
Conclusion
 The IDS-iSYS InaKtif MGP is the first fully automated dp-ucMGP kit 
which will be soon available commercially for the measuring of the 
dephosphor-uncarboxylated MGP levels. 
 Different observations in the studies that used the ELISA method might 
be explained by its poor linearity in the higher range.
 The dp-ucMGP blood test could be included as part of routine 
monitoring biomarkers for hemodialysis patients after further proven its 
clinical validity.
- iSYS = 1.26 x (ELISA) + 420 pM; 95% Cl slope: 1.16 – 1.36.
- Pearson correlation r = 0.89 (P<0.0001); 95% Cl: 0.86 - 0.92.
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